There were 447 press releases posted in the last 24 hours and 428,953 in the last 365 days.

Senate Resolution 191 Printer's Number 1296

PENNSYLVANIA, November 5 - individual will eventually be diagnosed with Type 2 diabetes;

and

WHEREAS, Risk factors for diabetes include genetic factors,

high blood pressure, low HDL cholesterol or high triglycerides,

gestational diabetes during pregnancy, being 45 years of age or

older, being a member of a high-risk ethnic group, being

overweight and having an inactive lifestyle; and

WHEREAS, According to the most recent National Diabetes

Statistics Report released by the CDC, approximately 38.4

million individuals, or roughly 11.6% of the United States

population, both adults and adolescents, live with the disease;

and

WHEREAS, Of this number approximately 8.7 million, or nearly

23%, are undiagnosed; and

WHEREAS, Approximately 11.1% of Pennsylvanians live with some

form of diagnosed diabetes, with an additional estimated 3%

living undiagnosed, according to the most updated information

from the American Diabetes Association (ADA); and

WHEREAS, The most recent data from the CDC states that

diabetes contributed to approximately 95,000 deaths nationwide

and 4,124 deaths in Pennsylvania; and

WHEREAS, Diabetes is one of the seven leading causes of

health-related deaths in this Commonwealth; and

WHEREAS, The rate of deaths related to diabetes has increased

over the past four decades; and

WHEREAS, There is currently no cure for diabetes but an

individual's risk of developing Type 2 diabetes can be greatly

reduced through a healthy diet, physical activity and

medication; and

WHEREAS, The majority of avoidable costs associated with

20250SR0191PN1296 - 2 -

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.